Cycle Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CYCLE, and when can generic versions of CYCLE drugs launch?
CYCLE has thirteen approved drugs.
There are four US patents protecting CYCLE drugs.
There are sixteen patent family members on CYCLE drugs in eighteen countries and twenty-four supplementary protection certificates in thirteen countries.
Summary for Cycle
| International Patents: | 16 |
| US Patents: | 4 |
| Tradenames: | 10 |
| Ingredients: | 10 |
| NDAs: | 13 |
Drugs and US Patents for Cycle
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cycle | PIROXICAM | piroxicam | CAPSULE;ORAL | 073651-001 | Feb 26, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Cycle | PIROXICAM | piroxicam | CAPSULE;ORAL | 073651-002 | Feb 26, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Cycle | CIMETIDINE | cimetidine | TABLET;ORAL | 074361-001 | Dec 23, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Cycle | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | SOLUTION;ORAL | 074541-001 | Aug 5, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Cycle | CIMETIDINE | cimetidine | TABLET;ORAL | 074361-002 | Dec 23, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Cycle Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Cyprus | 1123394 | ⤷ Try a Trial |
| Denmark | 3089740 | ⤷ Try a Trial |
| Canada | 2974375 | ⤷ Try a Trial |
| European Patent Office | 3089740 | ⤷ Try a Trial |
| China | 107530301 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Cycle Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0627406 | 11C0021 | France | ⤷ Try a Trial | PRODUCT NAME: FINGOLIMOD ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES EN PARTICULIER SON CHLORHYDRATE; REGISTRATION NO/DATE: EU/1/11/677/001 20110317 |
| 0627406 | 1190015-6 | Sweden | ⤷ Try a Trial | PRODUCT NAME: FINGOLIMOD; REG. NO/DATE: EU/1/11/677/001-04 20110317 |
| 1539166 | 2013/055 | Ireland | ⤷ Try a Trial | PRODUCT NAME: THE COMBINATION OF: (A) DEXTROMETHORPHAN OR A PHARMACEUTICALLY ACCEPTABLE SALT, PRECURSOR OR DERIVATIVE THEREOF, E.G. DEXTROMETHORPHAN HYDROBROMIDE AND IN PARTICULAR DEXTROMETHORPHAN HYDROBROMIDE MONOHYDRATE; AND (B) QUINIDINE OR A PHARMACEUTICALLY ACCEPTABLE SALT, PRECURSOR OR DERIVATIVE THEREOF, E.G. QUINIDINE SULPHATE AND IN PARTICULAR QUINIDINE SULPHATE DIHYDRATE, PROTECTED BY THE BASIC PATENT; REGISTRATION NO/DATE: EU/1/13/833 20130624 |
| 0627406 | 2011020 | Ireland | ⤷ Try a Trial | PRODUCT: GILENYA FINGOLIMOD AND/OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF REGISTRATION NO/DATE: IRELAND EU/1/11/677/001, EU/1/11/677/002, EU/1/11/677/003, EU/1/11/677/004 / 17/03/2011; FIRST REGISTRATION NO/DATE: EUROPEAN UNION EU/1/11/677/001, EU/1/11/677/002, EU/1/11/677/003, EU/1/11/677/004 / 17/03/2011 |
| 1539166 | 2013C/064 | Belgium | ⤷ Try a Trial | PRODUCT NAME: DEXTROMETHORPHANE OU UN SEL, PRCURSEUR DE DERIVE PHARMACEUTIQUEMENT ACCEPTABLE, PAR EXEMPLE LE BROMHYDRURE DE DEXTROMETORPHANE ET EN PARTICULIER LE BROMHYDRURE DE DEXTROMETROPHANE MONHYDRATE ET QUINIDINE OU UN SEL,....; AUTHORISATION NUMBER AND DATE: EU/1/13/833 20130626 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
